The 30th Annual Diabetes Day: Therapeutics and Technology is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. The goal of this symposium is to increase practitioners’ competence and clinical performance in treating diabetes and its complications and, ultimately, to improve patient outcomes.
Key topic areas that will be addressed include:
- MASLD, new consensus guidelines
- Tirzepatide cardiac outcomes
- GLP-1 agonist vs SGLT-2 Inhibitors vs Multi-agonist Therapy
- Latest technology in insulin pumps
- Review of therapeutic options to manage both Type 1 and 2 diabetes
- Technology Updates in Pregnancy
- Role of amyloid in pathogenesis of diabetes and dementia
- And much more
Attendees will be able to:
- Critically appraise clinical evidence and guidelines supporting hybrid closed-loop systems in pregnancy and identify key considerations when initiating and monitoring hybrid closed-loop pumps during pregnancy.
- Describe the efficacy of inhaled insulin to insulin pump therapy in diabetes management.
- Discuss the role of nutritional supplements in the management of Type 2 diabetes and glycemic control, including the use of berberine.
- Discuss future directions and challenges in developing and implementing oral GLP-1 agonists and multi-agonist therapy in diabetes care and summarize clinical evidence on the incidence and risk of gastroparesis, pancreatitis, and thyroid cancer associated with GLP-1 agonist use.
- Analyze current research and define treatment strategies for challenges in diabetes care, including dementia, blood pressure, including intensive blood pressure control, and cardiovascular and renal complications in diabetes.
- Discuss evidence-based treatment strategies for post-gastric bypass hypoglycemia, including dietary modifications, pharmacotherapy, and other interventions.
- Discuss practical considerations for initiating and titrating novel therapies such as efsitora alfa in different patient populations, including those with complex diabetes management needs.
Who should attend?
This activity is designed for physicians, diabetes educators, nurses, nurse practitioners, pharmacists, pharmacy technicians, physician assistants, residents and fellows, and other health care professionals who care for patients with diabetes.